Abstract
Purpose
To determine the outcomes and to identify prognostic variables determining mortality and recurrence after surgery for renal cell cancer (RCC) with venous involvement.
Methods
Retrospective evaluation of the medical records of 132 patients with RCC and tumor thrombi treated at Johns Hopkins Hospital (1997–2008) was done. Kaplan–Meier analysis was used to determine survivals. Uni- and multivariate Cox proportional analysis was done to identify predictors for recurrence, all-cause mortality (ACM) and cancer-specific mortality (CSM).
Results
Mean follow-up was 30.3 (0.03–159.5) months. Sixty-four (48.5 %) patients had renal vein thrombus (Group 1), 55 (41.7 %) had subdiaphragmatic inferior vena cava (IVC) tumor thrombus (Group 2), while 13 (9.8 %) had involvement of IVC above diaphragm or atrial extension (Group 3). IVC thrombus was more common from the right-sided tumors. Patients with higher thrombus levels had more blood loss and complicated and longer hospital stay.
Thrombus level was not found to be a predictor of recurrence, ACM and CSM. One- and three-year recurrence-free survivals for non-metastatic patients were 69 and 53 %. Tumor size (p = 0.015), grade (p = 0.007) and venous wall invasion (p = 0.027) were predictors for recurrence. Five-year overall survival was 48, 35 and 13 % for 3 groups, respectively. Presence of distant metastasis (p = 0.032), size (p = 0.002), histology (p = 0.020) and grade (p = 0.013) were predictors of ACM. Five-year cancer-specific survival was 65, 43 and 36 for 3 groups, respectively. Tumor size (p = 0.001) and distant metastasis at presentation (p = 0.025) were the predictors of CSM.
Conclusions
Tumor thrombus level does not predict recurrence or mortality in RCC with venous involvement. Survival is determined by inherent aggressiveness of the cancer manifested by tumor size, grade and distant metastasis at presentation.
Similar content being viewed by others
References
Marshall FF, Dietrick DD, Baumgartner WA, Reitz BA (1988) Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins. J Urol 139(6):1166–1172
Gettman MT, Blute ML (2002) Surgical management of renal cell carcinoma invading the vena cava. Curr Urol Rep 3(1):37–43
Staehler G, Brkovic D (2000) The role of radical surgery for renal cell carcinoma with extension into the vena cava. J Urol 163(6):1671–1675
Swierzewski DJ, Swierzewski MJ, Libertino JA (1994) Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension. Am J Surg 168(2):205–209
Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC (2005) Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 104(1):53–60
Wagner B, Patard JJ, Mejean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valeri A, Meyer N, Jacqmin D, Lang H (2009) Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 55(2):452–459
Moinzadeh A, Libertino JA (2004) Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 171(2 Pt 1):598–601
Parekh DJ, Cookson MS, Chapman W, Harrell F Jr, Wells N, Chang SS, Smith JA Jr (2005) Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. J Urol 173(6):1897–1902
Polascik TJ, Partin AW, Pound CR, Marshall FF (1998) Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis. Urology 52(6):995–999
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Libertino JA, Zinman L, Watkins E Jr (1987) Long-term results of resection of renal cell cancer with extension into inferior vena cava. J Urol 137(1):21–24
Neves RJ, Zincke H (1987) Surgical treatment of renal cancer with vena cava extension. Br J Urol 59(5):390–395
Skinner DG, Pfister RF, Colvin R (1972) Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol 107(5):711–716
Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171(3):1071–1076
Pouliot F, Shuch B, Larochelle JC, Pantuck A, Belldegrun AS (2010) Contemporary management of renal tumors with venous tumor thrombus. J Urol 184(3):833–841; quiz 1235
Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS (2007) Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 178(4 Pt 1):1189–1195; discussion 1195
Manassero F, Mogorovich A, Di Paola G, Valent F, Perrone V, Signori S, Boggi U, Selli C (2011) Renal cell carcinoma with caval involvement: contemporary strategies of surgical treatment. Urol Oncol 29(6):745–750
Martinez-Salamanca JI, Huang WC, Millan I, Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernandez C, Herranz F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martinez-Ballesteros C, Montorsi F, Palou J, Pontes JE, Russo P, Terrone C, Villavicencio H, Volpe A, Libertino JA (2011) Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol 59(1):120–127
Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H (2004) The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 94(1):33–41
Gettman MT, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML (2003) Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 169(4):1282–1286
Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML (2005) Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol 173(3):716–719
Klaver S, Joniau S, Suy R, Oyen R, Van Poppel H (2008) Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b). BJU Int 101(4):444–449
Haferkamp A, Bastian PJ, Jakobi H, Pritsch M, Pfitzenmaier J, Albers P, Hallscheidt P, Muller SC, Hohenfellner M (2007) Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. J Urol 177(5):1703–1708
Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS (2004) Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 171(2 Pt 1):588–591
Montie JE, el Ammar R, Pontes JE, Medendorp SV, Novick AC, Streem SB, Kay R, Montague DK, Cosgrove DM (1991) Renal cell carcinoma with inferior vena cava tumor thrombi. Surg Gynecol Obstet 173(2):107–115
Bertini R, Roscigno M, Freschi M, Angiolilli D, Strada E, Petralia G, Sozzi F, Capitanio U, Cremonini A, Rigatti P (2011) The extent of tumour fat invasion affects survival in patients with renal cell carcinoma and venous tumour thrombosis. BJU Int 108(6):820–824
Terrone C, Gontero P, Volpe A, Porpiglia F, Bollito E, Zattoni F, Frea B, Tizzani A, Fontana D, Scarpa RM, Rossetti SR (2008) Proposal of an improved prognostic classification for pT3 renal cell carcinoma. J Urol 180(1):72–78
Conflict of interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidana, A., Goyal, J., Aggarwal, P. et al. Determinants of outcomes after resection of renal cell carcinoma with venous involvement. Int Urol Nephrol 44, 1671–1679 (2012). https://doi.org/10.1007/s11255-012-0314-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-012-0314-x